Therapeutic applications of reconstituted HDL: When structure meets function

Pharmacology and Therapeutics

Volumn 157, Issue , 2016, Pages 28-42

  Darabi, Maryam ^a   Guillas Baudouin, Isabelle ^a   Le Goff, Wilfried ^a   Chapman, M John ^a   Kontush, Anatol ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Cardiovascular disease; Functionality; High density lipoprotein; Lipidomics; rHDL; Synthetic HDL

Indexed keywords

ATHEROPROTECTIVE AGENT; HIGH DENSITY LIPOPROTEIN; NEGATIVELY CHARGED PHOSPHOLIPID; PHOSPHATIDIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PROTECTIVE AGENT; RECONSTITUTED HIGH DENSITY LIPOPROTEIN; SPHINGOMYELIN; UNCLASSIFIED DRUG; PHOSPHOLIPID;

ARTICLE; ATHEROPROTECTIVE ACTIVITY; DRUG ACTIVITY; DRUG CLASSIFICATION; DRUG DESIGN; DRUG FORMULATION; DRUG METABOLISM; DRUG STRUCTURE; HEART PROTECTION; HUMAN; INTRACELLULAR SIGNALING; NONHUMAN; PHOSPHOLIPID METABOLISM; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); STRUCTURE ACTIVITY RELATION; ANIMAL; CHEMISTRY;

ANIMALS; HUMANS; LIPOPROTEINS, HDL; PHOSPHOLIPIDS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84951749312     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2015.10.010     Document Type: Review

References (220)

1. M. Alami, K. Dalal, B. Lelj-Garolla, S.G. Sligar, and F. Duong Nanodiscs unravel the interaction between the SecYEG channel and its cytosolic partner SecA EMBO J 26 2007 1995 2004
2. E.T. Alexander, G.L. Weibel, M.R. Joshi, C. Vedhachalam, M. De La Llera-Moya, G.H. Rothblat, and et al. Macrophage reverse cholesterol transport in mice expressing ApoA-I Milano Arterioscler Thromb Vasc Biol 29 2009 1496 1501
3. T.M. Allen, and A. Chonn Large unilamellar liposomes with low uptake into the reticuloendothelial system FEBS Lett 223 1987 42 46
4. T.M. Allen, C. Hansen, and J. Rutledge Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues Biochim Biophys Acta 981 1989 27 35
5. Y. Aramaki, R. Matsuno, and S. Tsuchiya Involvement of p38 MAP kinase in the inhibitory effects of phosphatidylserine liposomes on nitric oxide production from macrophages stimulated with LPS Biochem Biophys Res Commun 280 2001 982 987
6. I. Arimoto, H. Saito, Y. Kawashima, K. Miyajima, and T. Handa Effects of sphingomyelin and cholesterol on lipoprotein lipase-mediated lipolysis in lipid emulsions J Lipid Res 39 1998 143 151
7. K. Athenstaedt, and G. Daum Phosphatidic acid, a key intermediate in lipid metabolism Eur J Biochem FEBS 266 1999 1 16
8. M. Bamberger, J.M. Glick, and G.H. Rothblat Hepatic lipase stimulates the uptake of high density lipoprotein cholesterol by hepatoma cells J Lipid Res 24 1983 869 876
9. W.H.J. Beck, C.P. Adams, I.M. Biglang-awa, A.B. Patel, H. Vincent, E.J. Haas-Stapleton, and et al. Apolipoprotein A-I binding to anionic vesicles and lipopolysaccharides: role for lysine residues in antimicrobial properties Biochim Biophys Acta Biomembr 1828 2013 1503 1510
10. S.E. Bellibas, B. Zerler, H. Kempen, D. Goundis, and P. Wijngaard Pharmacokinetics and pharmacodynamics of mdco-216 (apoa-1 Milano/popc complex), a reverse cholesterol transport (rct) inducer in cynomolgus monkeys after single dose and 6 weeks of treatment Clin Pharmacol Ther 91 2012 A13357-A13357 (Abstract)
11. C. Bergmeier, R. Siekmeier, and W. Gross Distribution spectrum of paraoxonase activity in HDL fractions Clin Chem 50 2004 2309 2315
12. C. Besler, K. Heinrich, L. Rohrer, C. Doerries, M. Riwanto, D.M. Shih, and et al. Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease J Clin Investig 121 2011 2693 2708
13. C.H. Best, J.M. Hershey, and M.E. Huntsman The effect of lecithin on fat deposition in the liver of the normal rat J Physiol 75 1932 56 66
14. M. Biermann, C. Maueröder, J.M. Brauner, R. Chaurio, C. Janko, M. Herrmann, and et al. Surface code - biophysical signals for apoptotic cell clearance Phys Biol 10 2013 065007
15. D.J. Bolin, and A. Jonas Sphingomyelin inhibits the lecithin-cholesterol acyltransferase reaction with reconstituted high density lipoproteins by decreasing enzyme binding J Biol Chem 271 1996 19152 19158
16. W.B. Bollag, D. Xie, X. Zheng, and X. Zhong A potential role for the phospholipase D2-aquaporin-3 signaling module in early keratinocyte differentiation: production of a phosphatidylglycerol signaling lipid J Invest Dermatol 127 2007 2823 2831
17. J.G. Boucher, T. Nguyen, and D.L. Sparks Lipoprotein electrostatic properties regulate hepatic lipase association and activity Biochem Cell Biol 85 2007 696 708
18. J.P. Bradshaw, R.J. Bushby, C.C.D. Giles, and M.R. Saunders Orientation of the headgroup of phosphatidylinositol in a model biomembrane as determined by neutron diffraction Biochemistry 38 1999 8393 8401
19. S. Braschi, T.A. Neville, M.C. Vohl, and D.L. Sparks Apolipoprotein A-I charge and conformation regulate the clearance of reconstituted high density lipoprotein in vivo J Lipid Res 40 1999 522 532
20. W.C. Breckenridge, and F.B. Palmer Fatty acid composition of human plasma lipoprotein phosphatidylinositols Biochim Biophys Acta 712 1982 707 711
21. D. Breznan, V. Veereswaran, F.J. Viau, T.A.-M. Neville, and D.L. Sparks The lipid composition of high-density lipoprotein affects its re-absorption in the kidney by proximal tubule epithelial cells Biochem J 379 2004 343 349
22. M.F. Brodde, S.J.A. Korporaal, G. Herminghaus, M. Fobker, T.J.C. Van Berkel, U.J.F. Tietge, and et al. Native high-density lipoproteins inhibit platelet activation via scavenger receptor BI. Role of negatively charged phospholipids Atherosclerosis 215 2011 374 382
23. J.W. Burgess, J. Boucher, T.A.-M. Neville, P. Rouillard, C. Stamler, S. Zachariah, and et al. Phosphatidylinositol promotes cholesterol transport and excretion J Lipid Res 44 2003 1355 1363
24. J.W. Burgess, T.A.-M. Neville, P. Rouillard, Z. Harder, D.S. Beanlands, and D.L. Sparks Phosphatidylinositol increases HDL-C levels in humans J Lipid Res 46 2005 350 355
25. L. Calabresi, M. Canavesi, F. Bernini, and G. Franceschini Cell cholesterol efflux to reconstituted high-density lipoproteins containing the apolipoprotein A-I(Milano) dimer Biochemistry 38 1999 16307 16314
26. L. Camont, M. Lhomme, F. Rached, W. Le Goff, A. Nègre-Salvayre, R. Salvayre, and et al. Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities Arterioscler Thromb Vasc Biol 33 2013 2715 2723
27. S. Chantepie, A.E. Bochem, M.J. Chapman, G.K. Hovingh, and A. Kontush High-density lipoprotein (HDL) particle subpopulations in heterozygous cholesteryl ester transfer protein (CETP) deficiency: maintenance of antioxidative activity PLoS One 7 2012 e49336
28. S. Chen, and P.V. Subbaiah Phospholipid and fatty acid specificity of endothelial lipase: potential role of the enzyme in the delivery of docosahexaenoic acid (DHA) to tissues Biochim Biophys Acta Mol Cell Biol Lipids 1771 2007 1319 1328
29. N. Cheong, M. Madesh, L.W. Gonzales, M. Zhao, K. Yu, P.L. Ballard, and et al. Functional and trafficking defects in ATP binding cassette A3 mutants associated with respiratory distress syndrome J Biol Chem 281 2006 9791 9800
30. G. Chiesa, and C.R. Sirtori Apolipoprotein A-I(Milano): current perspectives Curr Opin Lipidol 14 2003 159 163
31. M.T. Childs, J.A. Bowlin, J.T. Ogilvie, W.R. Hazzard, and J.J. Albers The contrasting effects of a dietary soya lecithin product and corn oil on lipoprotein lipids in normolipidemic and familial hypercholesterolemic subjects Atherosclerosis 38 1981 217 228
32. X. Collet, B. Perret, F. Chollet, F. Hullin, H. Chap, and L. Douste-Blazy Uptake of HDL unesterified and esterified cholesterol by human endothelial cells. Modulation by HDL phospholipolysis and cell cholesterol content Biochim Biophys Acta 958 1988 81 92
33. A. Ćwiklińska, B. Kortas-Stempak, A. Gliwińska, A. Pacanis, A. Kuchta, and M. Wróblewska Interaction between VLDL and phosphatidylcholine liposomes generates new γ-LpE-like particles Lipids 49 2014 143 153
34. B. Dahlbäck, and L.B. Nielsen Apolipoprotein M affecting lipid metabolism or just catching a ride with lipoproteins in the circulation? Cell Mol Life Sci 66 2009 559 564
35. J. Dalla-Riva, K.G. Stenkula, J. Petrlova, and J.O. Lagerstedt Discoidal HDL and apoA-I-derived peptides improve glucose uptake in skeletal muscle J Lipid Res 54 2013 1275 1282
36. M. Darabi, and A. Kontush Biochimie can phosphatidylserine enhance atheroprotective activities of high-density lipoprotein. Biochimie 2015 10.1016/j.biochi.2015.06.022
37. W.S. Davidson, K.L. Gillotte, S. Lund-Katz, W.J. Johnson, G.H. Rothblat, and M.C. Phillips The effect of high density lipoprotein phospholipid acyl chain composition on the efflux of cellular free cholesterol J Biol Chem 270 1995 5882 5890
38. W.S. Davidson, R.A.G.D. Silva, S. Chantepie, W.R. Lagor, M.J. Chapman, and A. Kontush Proteomic analysis of defined HDL subpopulations reveals particle-specific protein clusters: relevance to antioxidative function Arterioscler Thromb Vasc Biol 29 2009 870 876
39. W.S. Davidson, D.L. Sparks, S. Lund-Katz, and M.C. Phillips The molecular basis for the difference in charge between pre-beta- and alpha-migrating high density lipoproteins J Biol Chem 269 1994 8959 8965
40. H. Deguchi, J.A. Fernandez, T.M. Hackeng, C.L. Banka, and J.H. Griffin Cardiolipin is a normal component of human plasma lipoproteins Proc Natl Acad Sci U S A 97 2000 1743 1748
41. R.M. DeKroon, M. Mihovilovic, Z.V. Goodger, J.B. Robinette, P.M. Sullivan, A.M. Saunders, and et al. ApoE genotype-specific inhibition of apoptosis J Lipid Res 44 2003 1566 1573
42. C.J. DeLong, Y.J. Shen, M.J. Thomas, and Z. Cui Molecular distinction of phosphatidylcholine synthesis between the CDP-choline pathway and phosphatidylethanolamine methylation pathway J Biol Chem 274 1999 29683 29688
43. G. Di-Paolo, and P. De Camilli Phosphoinositides in cell regulation and membrane dynamics Nature 443 2006 651 657
44. J. Drain, J.R. Bishop, and S.L. Hajduk Haptoglobin-related protein mediates trypanosome lytic factor binding to trypanosomes J Biol Chem 276 2001 30254 30260
45. P.T. Duong, H.L. Collins, M. Nickel, S. Lund-Katz, G.H. Rothblat, and M.C. Phillips Characterization of nascent HDL particles and microparticles formed by ABCA1-mediated efflux of cellular lipids to apoA-I J Lipid Res 47 2006 832 843
46. G. Dvoriantchikova, C. Agudelo, E. Hernandez, V.I. Shestopalov, and D. Ivanov Phosphatidylserine-containing liposomes promote maximal survival of retinal neurons after ischemic injury J Cereb Blood Flow Metab 29 2009 1755 1759
47. R. Easton, A. Gille, D. D'Andrea, R. Davis, S.D. Wright, and C. Shear A multiple ascending dose study of CSL112, an infused formulation of ApoA-I J Clin Pharmacol 54 2014 301 310
48. R. Ehehalt, A. Braun, M. Karner, J. Füllekrug, and W. Stremmel Phosphatidylcholine as a constituent in the colonic mucosal barrier - physiological and clinical relevance Biochim Biophys Acta Mol Cell Biol Lipids 1801 2010 983 993
49. G. Eros, S. Ibrahim, N. Siebert, M. Boros, and B. Vollmar Oral phosphatidylcholine pretreatment alleviates the signs of experimental rheumatoid arthritis Arthritis Res Ther 11 2009 R43
50. G. Erõs, G. Varga, R. Váradi, M. Czóbel, J. Kaszaki, M. Ghyczy, and et al. Anti-inflammatory action of a phosphatidylcholine, phosphatidylethanolamine and N-acylphosphatidylethanolamine-enriched diet in carrageenan-induced pleurisy Eur Surg Res 42 2008 40 48
51. V.A. Fadok, D.L. Bratton, D.M. Rose, A. Pearson, R.A. Ezekewitz, and P.M. Henson A receptor for phosphatidylserine-specific clearance of apoptotic cells Nature 405 2000 85 90
52. N. Fidge, P. Nestel, T. Ishikawa, M. Reardon, and T. Billington Turnover of apoproteins AI and A-II of high density lipoprotein and the relationship to other lipoproteins in normal and hyperlipidemic individuals Metabolism 29 1980 643 653
53. S.K. Fisher, J.E. Novak, and B.W. Agranoff Inositol and higher inositol phosphates in neural tissues: homeostasis, metabolism and functional significance J Neurochem 82 2002 736 754
54. M.L. Fitzgerald, R. Xavier, K.J. Haley, R. Welti, J.L. Goss, C.E. Brown, and et al. ABCA3 inactivation in mice causes respiratory failure, loss of pulmonary surfactant, and depletion of lung phosphatidylglycerol J Lipid Res 48 2007 621 632
55. N. Fournier, J.L. Paul, V. Atger, A. Cogny, T. Soni, M. de la Llera-Moya, and et al. HDL phospholipid content and composition as a major factor determining cholesterol efflux capacity from Fu5AH cells to human serum Arterioscler Thromb Vasc Biol 17 1997 2685 2691
56. E.K. Fridriksson, P.A. Shipkova, E.D. Sheets, D. Holowka, B. Baird, and F.W. McLafferty Quantitative analysis of phospholipids in functionally important membrane domains from RBL-2H3 mast cells using tandem high-resolution mass spectrometry Biochemistry 38 1999 8056 8063
57. M. Fukuda, M. Nakano, S. Sriwongsitanont, M. Ueno, Y. Kuroda, and T. Handa Spontaneous reconstitution of discoidal HDL from sphingomyelin-containing model membranes by apolipoprotein A-I J Lipid Res 48 2007 882 889
58. A. Gabizon, and D. Papahadjopoulos Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors Proc Natl Acad Sci U S A 85 1988 6949 6953
59. H.J. Galla, and E. Sackmann Chemically induced lipid phase separation in model membranes containing charged lipids: a spin label study Biochim Biophys Acta 401 1975 509 529
60. C.R. Gault, L.M. Obeid, and Y.A. Hannun An overview of sphingolipid metabolism: from synthesis to breakdown Adv Exp Med Biol 688 2010 1 23
61. A. Gille, R. Easton, D. D'Andrea, S.D. Wright, and C.L. Shear CSL112 enhances biomarkers of reverse cholesterol transport after single and multiple infusions in healthy subjects Arterioscler Thromb Vasc Biol 34 2014 2106 2114
62. A. Gille, R. Easton, S. Wright, and C. Shear CSL112, a novel formulation of human apolipoprotein A-I, dramatically increases cholesterol efflux capacity in healthy subjects: a placebo-controlled, double-blinded, randomized single ascending dose study Circulation 2012 126 (Abstract, A11855)
63. M. Gobbi, F. Re, M. Canovi, M. Beeg, M. Gregori, S. Sesana, and et al. Lipid-based nanoparticles with high binding affinity for amyloid-beta1-42 peptide Biomaterials 31 2010 6519 6529
64. M.E. Greenberg, M. Sun, R. Zhang, M. Febbraio, R. Silverstein, and S.L. Hazen Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells J Exp Med 203 2006 2613 2625
65. K. Gulshan, and J.D. Smith Sphingomyelin regulation of plasma membrane asymmetry, efflux and reverse cholesterol transport Clin Lipidol 9 2014 383 393
66. M.E. Haberland, and J.A. Reynolds Interaction of l-alpha-palmitoyl lysophosphatidylcholine with the AI polypeptide of high density lipoprotein J Biol Chem 250 1975 6636 6639
67. B. Haidar, S. Mott, B. Boucher, C.Y. Lee, M. Marcil, and J. Genest Cellular cholesterol efflux is modulated by phospholipid-derived signaling molecules in familial HDL deficiency/Tangier disease fibroblasts J Lipid Res 42 2001 249 257
68. S. Hara, T. Shike, N. Takasu, and T. Mizui Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells Arterioscler Thromb Vasc Biol 17 1997 1258 1266
69. W. Hartmann, H.-J. Galla, and E. Sackmann Direct evidence of charge-induced lipid domain structure in model membranes FEBS Lett 78 1977 169 172
70. S. Hashioka, Y.-H. Han, S. Fujii, T. Kato, A. Monji, H. Utsumi, and et al. Phosphatidylserine and phosphatidylcholine-containing liposomes inhibit amyloid beta and interferon-gamma-induced microglial activation Free Radic Biol Med 42 2007 945 954
71. A.M. Hicks, C.J. DeLong, M.J. Thomas, M. Samuel, and Z. Cui Unique molecular signatures of glycerophospholipid species in different rat tissues analyzed by tandem mass spectrometry Biochim Biophys Acta 1761 2006 1022 1029
72. P.R. Hoffmann, J.A. Kench, A. Vondracek, E. Kruk, D.L. Daleke, M. Jordan, and et al. Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo J Immunol 174 2005 1393 1404
73. M. Holzer, R. Birner-Gruenberger, T. Stojakovic, D. El-Gamal, V. Binder, C. Wadsack, and et al. Uremia alters HDL composition and function J Am Soc Nephrol 22 2011 1631 1641
74. S. Hopewell, N.R. Pandey, A. Misquith, E. Twomey, and D.L. Sparks Phosphatidylinositol acts through mitogen-activated protein kinase to stimulate hepatic apolipoprotein A-I secretion Metab Clin Exp 57 2008 1677 1684
75. H. Hosseini, Y. Li, P. Kanellakis, C. Tay, A. Cao, P. Tipping, and et al. Phosphatidylserine liposomes mimic apoptotic cells to attenuate atherosclerosis by expanding polyreactive IgM producing B1a lymphocytes Cardiovasc Res 106 2015 443 452
76. M. Hou, M. Xia, H. Zhu, Q. Wang, Y. Li, Y. Xiao, and et al. Lysophosphatidylcholine promotes cholesterol efflux from mouse macrophage foam cells via PPARγ-LXRα-ABCA1-dependent pathway associated with apoE Cell Biochem Funct 25 2007 33 44
77. G.K. Hovingh, L.P. Smits, C. Stefanutti, H. Soran, S. Kwok, J. de Graaf, and et al. The effect of an apolipoprotein A-I-containing high-density lipoprotein-mimetic particle (CER-001) on carotid artery wall thickness in patients with homozygous familial hypercholesterolemia: the Modifying Orphan Disease Evaluation (MODE) study Am Heart J 169 2015 736 742.e1
78. G.K. Hovingh, E.S. Stroes, D. Gaudet, C. Stefanutti, H. Soran, S. Kwok, and et al. Effects of CER-001 on carotid atherosclerosis by 3tmri in homozygous familial hypercholesterolemia (HoFH): the modifying orphan disease evaluation (mode) study Atherosclerosis 235 2014 e13 e14 (Abstract)
79. J. Huang, H. Lee, A.M. Zivkovic, J.T. Smilowitz, N. Rivera, J.B. German, and et al. Glycomic analysis of high density lipoprotein shows a highly sialylated particle J Proteome Res 13 2014 681 691
80. R. Huang, R.A.G.D. Silva, W.G. Jerome, A. Kontush, M.J. Chapman, L.K. Curtiss, and et al. Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma Nat Struct Mol Biol 18 2011 416 422
81. E. Ikonen Cellular cholesterol trafficking and compartmentalization Nat Rev Mol Cell Biol 9 2008 125 138
82. R.L. Jacobs, S. Lingrell, Y. Zhao, G.A. Francis, and D.E. Vance Hepatic CTP:phosphocholine cytidylyltransferase-alpha is a critical predictor of plasma high density lipoprotein and very low density lipoprotein J Biol Chem 283 2008 2147 2155
83. T.R. Joy Novel HDL-based therapeutic agents Pharmacol Ther 135 2012 18 30
84. H. Kadowaki, G.M. Patton, and S.J. Robins Metabolism of high density lipoprotein lipids by the rat liver: evidence for participation of hepatic lipase in the uptake of cholesteryl ester J Lipid Res 33 1992 1689 1698
85. D.B. Kallend, B.F. Asztalos, J. Otvos, B. Eralp, and P.L.J. Wijngaard Single infusions of MDCO-216 (ApoA1 Milano/POPC) were well tolerated in healthy volunteers and in patients with stable CAD Circulation 130 2015 9907 (Abstract)
86. P. Kandasamy, S. Zarini, E.D. Chan, C.C. Leslie, R.C. Murphy, and D.R. Voelker Pulmonary surfactant phosphatidylglycerol inhibits Mycoplasma pneumoniae-stimulated eicosanoid production from human and mouse macrophages J Biol Chem 286 2011 7841 7853
87. H.J. Kempen, D.B. Schranz, B.F. Asztalos, J. Otvos, E. Jeyarajah, D. Drazul-Schrader, and et al. Incubation of MDCO-216 (ApoA-I Milano/POPC) with human serum potentiates ABCA1-mediated cholesterol efflux capacity, generates new prebeta-1 HDL, and causes an increase in HDL size J Lipids 2014 2014 923903
88. C.H. Keyserling, T.L. Hunt, H.M. Klepp, R.A. Scott, R. Barbaras, A. Schwendeman, and et al. CER-001, a synthetic HDL-mimetic, safely mobilizes cholesterol in healthy dyslipidemic volunteers Circulation 124 2011 A15525 (Abstract)
89. M.S. Khan, and K. Krishnaraj Phospholipids: a novel adjuvant in herbal drug delivery systems Crit Rev Ther Drug Carrier Syst 31 2014 407 428
90. T. Kimura, K. Sato, A. Kuwabara, H. Tomura, M. Ishiwara, I. Kobayashi, and et al. Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells J Biol Chem 276 2001 31780 31785
91. T. Kimura, K. Sato, E. Malchinkhuu, H. Tomura, K. Tamama, A. Kuwabara, and et al. High-density lipoprotein stimulates endothelial cell migration and survival through sphingosine 1-phosphate and its receptors Arterioscler Thromb Vasc Biol 23 2003 1283 1288
92. B.A. Kingwell, and M.J. Chapman Future of high-density lipoprotein infusion therapies: potential for clinical management of vascular disease Circulation 128 2013 1112 1121
93. B.A. Kingwell, M.J. Chapman, A. Kontush, and N.E. Miller HDL-targeted therapies: progress, failures and future Nat Rev Drug Discov 13 2014 445 464
94. R. Kirsten, B. Heintz, K. Nelson, K. Hesse, E. Schneider, G. Oremek, and et al. Polyenylphosphatidylcholine improves the lipoprotein profile in diabetic patients Int J Clin Pharmacol Ther 32 1994 53 56
95. R.S. Kiss, M.R. Elliott, Z. Ma, Y.L. Marcel, and K.S. Ravichandran Apoptotic cells induce a phosphatidylserine-dependent homeostatic response from phagocytes Curr Biol 16 2006 2252 2258
96. R.L. Kitchens, P.A. Thompson, S. Viriyakosol, G.E. O'Keefe, and R.S. Munford Plasma CD14 decreases monocyte responses to LPS by transferring cell-bound LPS to plasma lipoproteins J Clin Investig 108 2001 485 493
97. J.Y. Kiyasu, R.A. Pieringer, H. Paulus, and E.P. Kennedy The biosynthesis of phosphatidylglycerol J Biol Chem 238 1963 2293 2298
98. A. Kontush, and M.J. Chapman Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis Pharmacol Rev 58 2006 342 374
99. A. Kontush, and M.J. Chapman Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities Curr Opin Lipidol 21 2010 312 318
100. A. Kontush, and M.J. Chapman High-density lipoproteins: structure, metabolism, function and therapeutics 2012 John Wiley & Sons, Inc. Hoboken, NJ, USA
101. A. Kontush, M. Lhomme, and M.J. Chapman Unraveling the complexities of the HDL lipidome J Lipid Res 54 2013 2950 2963
102. A. Kontush, P. Therond, A. Zerrad, M. Couturier, A. Négre-Salvayre, J.A. de Souza, and et al. Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: relevance to antiapoptotic and antioxidative activities Arterioscler Thromb Vasc Biol 27 2007 1843 1849
103. A. Kontush, E. Tubeuf, W. Le Goff, C. Dauteuille, I. Guillas-Baudouin, M. Lhomme, and et al. Phosphatidylserine potently enhances anti-inflammatory activities of reconstituted HDL Atherosclerosis 241 2015 e30 (Abstract)
104. E.E. Kooijman, V. Chupin, N.L. Fuller, M.M. Kozlov, B. De Kruijff, K.N.J. Burger, and et al. Spontaneous curvature of phosphatidic acid and lysophosphatidic acid Biochemistry 44 2005 2097 2102
105. R.S. Kootte, L.P. Smits, F.M. van der Valk, J.-L. Dasseux, C.H. Keyserling, R. Barbaras, and et al. Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA J Lipid Res 56 2015 703 712
106. R. Leduc, G.M. Patton, D. Atkinson, and S.J. Robins Influence of different molecular species of phosphatidylcholine on cholesterol transport from lipoprotein recombinants in the rat J Biol Chem 262 1987 7680 7685
107. K.D. Lee, K. Hong, and D. Papahadjopoulos Recognition of liposomes by cells: in vitro binding and endocytosis mediated by specific lipid headgroups and surface charge density Biochim Biophys Acta 1103 1992 185 197
108. C.Y. Lee, A. Lesimple, M. Denis, J. Vincent, A. Larsen, O. Mamer, and et al. Increased sphingomyelin content impairs HDL biogenesis and maturation in human Niemann-Pick disease type B J Lipid Res 47 2006 622 632
109. J.Y. Lee, H.K. Min, D. Choi, and M.H. Moon Profiling of phospholipids in lipoproteins by multiplexed hollow fiber flow field-flow fractionation and nanoflow liquid chromatography-tandem mass spectrometry J Chromatogr A 1217 2010 1660 1666
110. M.A. Lemmon Membrane recognition by phospholipid-binding domains Nat Rev Mol Cell Biol 9 2008 99 111
111. S.-C. Lu, L. Atangan, K. Won Kim, M.M. Chen, R. Komorowski, C. Chu, and et al. An apoA-I mimetic peptibody generates HDL-like particles and increases alpha-1 HDL subfraction in mice J Lipid Res 53 2012 643 652
112. S. Lund-Katz, H.M. Laboda, L.R. McLean, and M.C. Phillips Influence of molecular packing and phospholipid type on rates of cholesterol exchange Biochemistry 27 1988 3416 3423
113. A. Lykidis, P.D. Jackson, C.O. Rock, and S. Jackowski The role of CDP-diacylglycerol synthetase and phosphatidylinositol synthase activity levels in the regulation of cellular phosphatidylinositol content J Biol Chem 272 1997 33402 33409
114. C.-I.J. Ma, J.A. Beckstead, A. Thompson, A. Hafiane, R.H.L. Wang, R.O. Ryan, and et al. Tweaking the cholesterol efflux capacity of reconstituted HDL Biochem Cell Biol 90 2012 636 645
115. J. Ma, X.-L. Liao, B. Lou, and M.-P. Wu Role of apolipoprotein A-I in protecting against endotoxin toxicity Acta Biochim Biophys Sin 36 2004 419 424
116. H.M. Ma, Z. Wu, and H. Nakanishi Phosphatidylserine-containing liposomes suppress inflammatory bone loss by ameliorating the cytokine imbalance provoked by infiltrated macrophages Lab Invest 91 2011 921 931
117. C.H. MacPhee, K.E. Moores, H.F. Boyd, D. Dhanak, R.J. Ife, C.A. Leach, and et al. Lipoprotein-associated phospholipase A2, platelet-activating factor acetylhydrolase, generates two bioactive products during the oxidation of low-density lipoprotein: use of a novel inhibitor Biochem J 338 Pt 2 1999 479 487
118. P. Marmillot, S. Patel, and M.R. Lakshman Reverse cholesterol transport is regulated by varying fatty acyl chain saturation and sphingomyelin content in reconstituted high-density lipoproteins Metab Clin Exp 56 2007 251 259
119. R. Martínez-Beamonte, J.M. Lou-Bonafonte, M.V. Martínez-Gracia, and J. Osada Sphingomyelin in high-density lipoproteins: structural role and biological function Int J Mol Sci 14 2013 7716 7741
120. A. Mashaghi, P. Partovi-Azar, T. Jadidi, N. Nafari, P. Maass, M.R.R. Tabar, and et al. Hydration strongly affects the molecular and electronic structure of membrane phospholipids J Chem Phys 136 2012 114709
121. S. Maté, J.V. Busto, A.B. García-Arribas, J. Sot, R. Vazquez, V. Herlax, and et al. N-nervonoylsphingomyelin (C24:1) prevents lateral heterogeneity in cholesterol-containing membranes Biophys J 106 2014 2606 2616
122. M. Miyata, and J.D. Smith Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides Nat Genet 14 1996 55 61
123. M. Miyazaki, Y. Tajima, Y. Ishihama, T. Handa, and M. Nakano Effect of phospholipid composition on discoidal HDL formation Biochim Biophys Acta Biomembr 1828 2013 1340 1346
124. J.E. Murphy, D. Tacon, P.R. Tedbury, J.M. Hadden, S. Knowling, T. Sawamura, and et al. LOX-1 scavenger receptor mediates calcium-dependent recognition of phosphatidylserine and apoptotic cells Biochem J 393 2006 107 115
125. M.N. Nanjee, C.J. Cooke, R. Garvin, F. Semeria, G. Lewis, W.L. Olszewski, and et al. Intravenous apoA-I/lecithin discs increase pre-beta-HDL concentration in tissue fluid and stimulate reverse cholesterol transport in humans J Lipid Res 42 2001 1586 1593
126. M.N. Nanjee, J.E. Doran, P.G. Lerch, and N.E. Miller Acute effects of intravenous infusion of ApoA1/phosphatidylcholine discs on plasma lipoproteins in humans Arterioscler Thromb Vasc Biol 19 1999 979 989
127. M. Navab, G.M. Ananthramaiah, S.T. Reddy, B.J. Van Lenten, B.J. Ansell, G.C. Fonarow, and et al. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL J Lipid Res 45 2004 993 1007
128. S.D. Nguyen, and D.E. Sok Preferable stimulation of PON1 arylesterase activity by phosphatidylcholines with unsaturated acyl chains or oxidized acyl chains at sn-2 position Biochim Biophys Acta Biomembr 1758 2006 499 508
129. S.J. Nicholls, E.M. Tuzcu, I. Sipahi, P. Schoenhagen, T. Crowe, S. Kapadia, and et al. Relationship between atheroma regression and change in lumen size after infusion of apolipoprotein A-I Milano 2006
130. A. Nilsson, and R.-D. Duan Absorption and lipoprotein transport of sphingomyelin J Lipid Res 47 2006 154 171
131. S.E. Nissen, T. Tsunoda, E.M. Tuzcu, P. Schoenhagen, C.J. Cooper, M. Yasin, and et al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial 2003
132. J.R. Nofer, and G. Assmann Atheroprotective effects of high-density lipoprotein-associated lysosphingolipids Trends Cardiovasc Med 15 2005 265 271
133. J.R. Nofer, R. Junker, E. Pulawski, M. Fobker, B. Levkau, A. Von Eckardstein, and et al. High density lipoproteins induce cell cycle entry in vascular smooth muscle cells via mitogen activated protein kinase-dependent pathway Thromb Haemost 85 2001 730 735
134. G.D. Norata, and A.L. Catapano Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL on the endothelium Vasc Health Risk Manag 1 2005 119 129
135. M. Numata, Y.V. Grinkova, J.R. Mitchell, H.W. Chu, S.G. Sligar, and D.R. Voelker Nanodiscs as a therapeutic delivery agent: inhibition of respiratory syncytial virus infection in the lung Int J Nanomedicine 8 2013 1417 1427
136. F. Okajima Plasma lipoproteins behave as carriers of extracellular sphingosine 1-phosphate: is this an atherogenic mediator or an anti-atherogenic mediator? Biochim Biophys Acta 1582 2002 132 137
137. B.N. Olsen, A.A. Bielska, T. Lee, M.D. Daily, D.F. Covey, P.H. Schlesinger, and et al. The structural basis of cholesterol accessibility in membranes Biophys J 105 2013 1838 1847
138. L. Ordóñez-Gutiérrez, F. Re, E. Bereczki, E. Ioja, M. Gregori, A.J. Andersen, and et al. Repeated intraperitoneal injection of liposomes containing phosphatidic acid and cardiolipin reduce amyloid-β levels in APP/PS1 transgenic mice Nanomed Nanotechnol Biol Med 11 2014 421 430
139. M.A. Ostos, M. Conconi, L. Vergnes, N. Baroukh, J. Ribalta, J. Girona, and et al. Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice Arterioscler Thromb Vasc Biol 21 2001 1023 1028
140. M. Otsuka, S. Tsuchiya, and Y. Aramaki Involvement of ERK, a MAP kinase, in the production of TGF-beta by macrophages treated with liposomes composed of phosphatidylserine Biochem Biophys Res Commun 324 2004 1400 1405
141. P.A. Oude Weernink, L. Han, K.H. Jakobs, and M. Schmidt Dynamic phospholipid signaling by G protein-coupled receptors Biochim Biophys Acta Biomembr 1768 2007 888 900
142. N.R. Pandey, and D.L. Sparks Phospholipids as cardiovascular therapeutics Curr Opin Investig Drugs 9 2008 281 285
143. S. Patel, B.G. Drew, S. Nakhla, S.J. Duffy, A.J. Murphy, P.J. Barter, and et al. Reconstituted high-density lipoprotein increases plasma high-density lipoprotein anti-inflammatory properties and cholesterol efflux capacity in patients with type 2 diabetes J Am Coll Cardiol 53 2009 962 971
144. A. Peng, D.S. Pisal, A. Doty, and S.V. Balu-Iyer Phosphatidylinositol induces fluid phase formation and packing defects in phosphatidylcholine model membranes Chem Phys Lipids 165 2012 15 22
145. G. Pepeu, I.M. Pepeu, and L. Amaducci A review of phosphatidylserine pharmacological and clinical effects. Is phosphatidylserine a drug for the ageing brain? Pharmacol Res 33 1996 73 80
146. F. Potì, M. Simoni, and J.R. Nofer Atheroprotective role of high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P) Cardiovasc Res 103 2014 395 404
147. H.J. Pownall, B.D. Hosken, B.K. Gillard, C.L. Higgins, H.Y. Lin, and J.B. Massey Speciation of human plasma high-density lipoprotein (HDL): HDL stability and apolipoprotein A-I partitioning Biochemistry 46 2007 7449 7459
148. H.J. Pownall, Q. Pao, and J.B. Massey Acyl chain and headgroup specificity of human plasma lecithin:cholesterol acyltransferase. Separation of matrix and molecular specificities J Biol Chem 260 1985 2146 2152
149. F.H. Rached, M.J. Chapman, and A. Kontush HDL particle subpopulations: focus on biological function Biofactors 41 2015 67 77
150. F. Rached, M. Lhomme, L. Camont, F. Gomes, C. Dauteuille, P. Robillard, and et al. Defective functionality of small, dense HDL3 subpopulations in ST segment elevation myocardial infarction: relevance of enrichment in lysophosphatidylcholine, phosphatidic acid and serum amyloid A Biochim Biophys Acta 1851 2015 1254 1261
151. F. Rached, R.D. Santos, L. Camont, M.H. Miname, M. Lhomme, C. Dauteuille, and et al. Defective functionality of HDL particles in familial apoA-I deficiency: relevance of alterations in HDL lipidome and proteome J Lipid Res 55 2014 2509 2520
152. R. Rao, J.J. Albers, G. Wolfbauer, and H.J. Pownall Molecular and macromolecular specificity of human plasma phospholipid transfer protein Biochemistry 36 1997 3645 3653
153. T.G. Redgrave, V. Rakic, B.C. Mortimer, and J.C.L. Mamo Effects of sphingomyelin and phosphatidylcholine acyl chains on the clearance of triacylglycerol-rich lipoproteins from plasma. Studies with emulsions in rats Biochim Biophys Acta Lipids Lipid Metab 1126 1992 65 72
154. A. Rigotti, S.L. Acton, and M. Krieger The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids J Biol Chem 270 1995 16221 16224
155. F. Rinninger, W.A. Mann, T. Kaiser, S. Ahle, N. Meyer, and H. Greten Hepatic lipase mediates an increase in selective uptake of high-density lipoprotein-associated cholesteryl esters by human Hep 3B hepatoma cells in culture Atherosclerosis 141 1998 273 285
156. M. Riwanto, L. Rohrer, B. Roschitzki, C. Besler, P. Mocharla, M. Mueller, and et al. Altered activation of endothelial anti- and proapoptotic pathways by high-density lipoprotein from patients with coronary artery disease: role of high-density lipoprotein-proteome remodeling Circulation 127 2013 891 904
157. W.V. Rodrigueza, S.K. Klimuk, P.H. Pritchard, and M.J. Hope Cholesterol mobilization and regression of atheroma in cholesterol-fed rabbits induced by large unilamellar vesicles Biochim Biophys Acta Biomembr 1368 1998 306 320
158. M. Rosenblat, and M. Aviram Paraoxonases role in the prevention of cardiovascular diseases Biofactors 35 2009 98 104
159. M. Rosenblat, J. Vaya, D. Shih, and M. Aviram Paraoxonase 1 (PON1) enhances HDL-mediated macrophage cholesterol efflux via the ABCA1 transporter in association with increased HDL binding to the cells: a possible role for lysophosphatidylcholine Atherosclerosis 179 2005 69 77
160. R.S. Rosenson, H.B. Brewer, B. Ansell, P. Barter, M.J. Chapman, J.W. Heinecke, and et al. Translation of high-density lipoprotein function into clinical practice: current prospects and future challenges Circulation 128 2013 1256 1267
161. X. Rousset, B. Vaisman, B. Auerbach, B.R. Krause, R. Homan, J. Stonik, and et al. Effect of recombinant human lecithin cholesterol acyltransferase infusion on lipoprotein metabolism in mice J Pharmacol Exp Ther 335 2010 140 148
162. K.-A. Rye, and P.J. Barter Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A.-I Arterioscler Thromb Vasc Biol 24 2004 421 428
163. K.A. Rye, M.A. Clay, and P.J. Barter Remodelling of high density lipoproteins by plasma factors Atherosclerosis 145 1999 227 238
164. M. Scherer, A. Böttcher, G. Schmitz, and G. Liebisch Sphingolipid profiling of human plasma and FPLC-separated lipoprotein fractions by hydrophilic interaction chromatography tandem mass spectrometry Biochim Biophys Acta 1811 2011 68 75
165. G.L. Scherphof, and J.A.A.M. Kamps The role of hepatocytes in the clearance of liposomes from the blood circulation Prog Lipid Res 40 2001 149 166
166. A. Schmidt, M. Wolde, C. Thiele, W. Fest, H. Kratzin, A.V. Podtelejnikov, and et al. Endophilin I mediates synaptic vesicle formation by transfer of arachidonate to lysophosphatidic acid Nature 401 1999 133 141
167. H. Schneider, A. Braun, J. Füllekrug, W. Stremmel, and R. Ehehalt Lipid based therapy for ulcerative colitis-modulation of intestinal mucus membrane phospholipids as a tool to influence inflammation Int J Mol Sci 11 2010 4149 4164
168. A. Shewan, D.J. Eastburn, and K. Mostov Phosphoinositides in cell architecture Cold Spring Harb Perspect Biol 3 2011 1 17
169. A. Siddhanta, and D. Shields Secretory vesicle budding from the trans-Golgi network is mediated by phosphatidic acid levels J Biol Chem 273 1998 17995 17998
170. I.M. Singh, M.H. Shishehbor, and B.J. Ansell High-density lipoprotein as a therapeutic target: a systematic review JAMA 298 2007 786 798
171. C.R. Sirtori, L. Calabresi, G. Franceschini, D. Baldassarre, M. Amato, J. Johansson, and et al. Cardiovascular status of carriers of the apolipoprotein A-I Milano mutant: the Limone sul Garda study Circulation 103 2001 1949 1954
172. J.P. Slotte, and L. Grönberg Oxidation of cholesterol in low density and high density lipoproteins by cholesterol oxidase J Lipid Res 31 1990 2235 2242
173. Y. Snitko, E.T. Yoon, and W. Cho High specificity of human secretory class II phospholipase A2 for phosphatidic acid Biochem J 321 1997 737 741
174. M.G. Sorci-Thomas, J.S. Owen, B. Fulp, S. Bhat, X. Zhu, J.S. Parks, and et al. Nascent high density lipoproteins formed by ABCA1 resemble lipid rafts and are structurally organized by three apoA-I monomers J Lipid Res 53 2012 1890 1909
175. D.L. Sparks, C. Chatterjee, E. Young, J. Renwick, and N.R. Pandey Lipoprotein charge and vascular lipid metabolism Chem Phys Lipids 154 2008 1 6
176. D.L. Sparks, P.G. Frank, and T.A. Neville Effect of the surface lipid composition of reconstituted LPA-I on apolipoprotein A-I structure and lecithin:cholesterol acyltransferase activity Biochim Biophys Acta 1390 1998 160 172
177. S. Spiegel, and S. Milstien Sphingosine-1-phosphate: an enigmatic signalling lipid Nat Rev Mol Cell Biol 4 2003 397 407
178. C.J. Stamler, D. Breznan, T.A. Neville, F.J. Viau, E. Camlioglu, and D.L. Sparks Phosphatidylinositol promotes cholesterol transport in vivo J Lipid Res 41 2000 1214 1221
179. L. Stuhne-Sekalec, and N.Z. Stanacev Biosynthesis of phosphatidylglycerol and phosphatidylglycerolphosphate in submitochondrial membranes isolated from guinea pig liver is absolutely dependent on CDP-diglycerides imported from microsomal membranes Biochem Cell Biol 68 1990 111 116
180. P.V. Subbaiah, L.R. Gesquiere, and K. Wang Regulation of the selective uptake of cholesteryl esters from high density lipoproteins by sphingomyelin J Lipid Res 46 2005 2699 2705
181. R. Sundler, and D. Papahadjopoulos Control of membrane fusion by phospholipid head groups. I. Phosphatidate/phosphatidylinositol specificity Biochim Biophys Acta 649 1981 743 750
182. W.K. Surewicz, R.M. Epand, H.J. Pownall, and S.W. Hui Human apolipoprotein A-I forms thermally stable complexes with anionic but not with zwitterionic phospholipids J Biol Chem 261 1986 16191 16197
183. D.D. Sviridov, A.Y. Misharin, I.G. Safonova, N.G. Bushmakina, V.S. Repin, and V.N. Smirnov Binding of partially reassembled high-density lipoprotein to isolated human small intestine epithelial cells. Effect of lipid composition Biochim Biophys Acta 963 1988 119 125
184. F. Tabet, K.C. Vickers, L.F. Cuesta Torres, C.B. Wiese, B.M. Shoucri, G. Lambert, and et al. HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells Nat Commun 5 2014 3292
185. K. Takahashi, Y. Kimura, N. Kioka, M. Matsuo, and K. Ueda Purification and ATPase activity of human ABCA1 J Biol Chem 281 2006 10760 10768
186. Y. Takasugi, F. Kurai, I. Kazume, M. Otsuka, Y. Negishi, R. Tada, and et al. Down regulation of MyD88 in macrophages treated with liposomes composed of phosphatidylserine Pharmacol Pharm 04 2013 248 254
187. P.K. Tarafdar, H. Chakraborty, S.M. Dennison, and B.R. Lentz Phosphatidylserine inhibits and calcium promotes model membrane fusion Biophys J 103 2012 1880 1889
188. J.-C. Tardif, C.M. Ballantyne, P. Barter, J.-L. Dasseux, Z.A. Fayad, M.-C. Guertin, and et al. Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial Eur Heart J 35 2014 3277 3286
189. J.-C. Tardif, J. Grégoire, P.L. L'Allier, R. Ibrahim, J. Lespérance, T.M. Heinonen, and et al. Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial JAMA 297 2007 1675 1682
190. C. Tardy, M. Goffinet, N. Boubekeur, R. Ackermann, G. Sy, A. Bluteau, and et al. CER-001, a HDL-mimetic, stimulates the reverse lipid transport and atherosclerosis regression in high cholesterol diet-fed LDL-receptor deficient mice Atherosclerosis 232 2014 110 118
191. -/- mice: evidence of ABCA1 down-regulation PLoS One 10 2015 e0137584
192. T. Thuren, P. Sisson, and M. Waite Hydrolysis of lipid mixtures by rat hepatic lipase Biochim Biophys Acta 1046 1990 178 184
193. P.P. Toth, P.J. Barter, R.S. Rosenson, W.E. Boden, M.J. Chapman, M. Cuchel, and et al. High-density lipoproteins: a consensus statement from the National Lipid Association J Clin Lipidol 7 2013 484 525
194. P. Tricoci, D.M. D'Andrea, P. Gurbel, M. Cuchel, B. Winston, R. Schott, and et al. Safety and tolerability of CSL112 in subjects with stable atherothrombotic disease: results from a phase 2a, multicenter, randomized, double-blind, placebo-controlled, ascending-dose study Circulation 128 2013 A18589 (Abstract)
195. F.M. Van't Hooft, T. Van Gent, and A. Van Tol Turnover and uptake by organs of radioactive serum high-density lipoprotein cholesteryl esters and phospholipids in the rat in vivo Biochem J 196 1981 877 885
196. J.E. Vance, and R. Steenbergen Metabolism and functions of phosphatidylserine Prog Lipid Res 44 2005 207 234
197. B.J. Van-Lenten, M. Navab, D. Shih, A.M. Fogelman, and A.J. Lusis The role of high-density lipoproteins in oxidation and inflammation Trends Cardiovasc Med 11 2001 155 161
198. G. Van-Meer, D.R. Voelker, and G.W. Feigenson Membrane lipids: where they are and how they behave Nat Rev Mol Cell Biol 9 2008 112 124
199. C. Vedhachalam, P.S. Chetty, M. Nickel, P. Dhanasekaran, S. Lund-Katz, G.H. Rothblat, and et al. Influence of apolipoprotein (Apo) A-I structure on nascent High Density Lipoprotein (HDL) particle size distribution J Biol Chem 285 2010 31965 31973
200. M. Volta, A. Bulfone, C. Gattuso, E. Rossi, M. Mariani, G.G. Consalez, and et al. Identification and characterization of CDS2, a mammalian homolog of the Drosophila CDP-diacylglycerol synthase gene Genomics 55 1999 68 77
201. A. Von-Eckardstein, J.R. Nofer, and G. Assmann High density lipoproteins and arteriosclerosis. Role of cholesterol efflux and reverse cholesterol transport Arterioscler Thromb Vasc Biol 21 2001 13 27
202. A. Von-Eckardstein, and C. Widmann High-density lipoprotein, beta cells, and diabetes Cardiovasc Res 2014 384 394
203. M. Walter, H. Reinecke, J.R. Nofer, U. Seedorf, and G. Assmann HDL3 stimulates multiple signaling pathways in human skin fibroblasts Arterioscler Thromb Vasc Biol 15 1995 1975 1986
204. X. Wang, S.P. Devaiah, W. Zhang, and R. Welti Signaling functions of phosphatidic acid Prog Lipid Res 45 2006 250 278
205. P.M. Weers, V. Narayanaswami, and R.O. Ryan Modulation of the lipid binding properties of the N-terminal domain of human apolipoprotein E3 Eur J Biochem FEBS 268 2001 3728 3735
206. P. Wiesner, K. Leidl, A. Boettcher, G. Schmitz, and G. Liebisch Lipid profiling of FPLC-separated lipoprotein fractions by electrospray ionization tandem mass spectrometry J Lipid Res 50 2008 574 585
207. G.F. Wilgram, S.W. Hartroft, and C.H. Best Dietary choline and the maintenance of the cardiovascular system in rats Br Med J 2 1954 1 5
208. T.A. Wilson, C.M. Meservey, and R.J. Nicolosi Soy lecithin reduces plasma lipoprotein cholesterol and early atherogenesis in hypercholesterolemic monkeys and hamsters: beyond linoleate Atherosclerosis 140 1998 147 153
209. W.-M.R. Wong, A.B. Gerry, W. Putt, J.L. Roberts, R.B. Weinberg, S.E. Humphries, and et al. Common variants of apolipoprotein A-IV differ in their ability to inhibit low density lipoprotein oxidation Atherosclerosis 192 2007 266
210. K. Wong, P.A. Valdez, C. Tan, S. Yeh, J.-A. Hongo, and W. Ouyang Phosphatidylserine receptor Tim-4 is essential for the maintenance of the homeostatic state of resident peritoneal macrophages Proc Natl Acad Sci U S A 107 2010 8712 8717
211. G.D. Wool, C.A. Reardon, and G.S. Getz Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties J Lipid Res 49 2008 1268 1283
212. M. Wróblewska, B. Kortas-Stempak, A. Szutowicz, and T. Badzio Phospholipids mediated conversion of HDLs generates specific apoA-II pre-beta mobility particles J Lipid Res 50 2009 667 675
213. Y. Wu, N. Tibrewal, and R.B. Birge Phosphatidylserine recognition by phagocytes: a view to a kill Trends Cell Biol 16 2006 189 197
214. Y. Yamauchi, M. Hayashi, S. Abe-Dohmae, and S. Yokoyama Apolipoprotein A-I activates protein kinase C alpha signaling to phosphorylate and stabilize ATP binding cassette transporter A1 for the high density lipoprotein assembly J Biol Chem 278 2003 47890 47897
215. P.G. Yancey, M. De La Llera-Moya, S. Swarnakar, P. Monzo, S.M. Klein, M.A. Connelly, and et al. High density lipoprotein phospholipid composition is a major determinant of the bi-directional flux and net movement of cellular free cholesterol mediated by scavenger receptor BI J Biol Chem 275 2000 36596 36604
216. P. Yang, N.A. Belikova, J. Billheimer, D.J. Rader, J.S. Hill, and P.V. Subbaiah Inhibition of endothelial lipase activity by sphingomyelin in the lipoproteins Lipids 49 2014 987 996
217. A. Zerrad-Saadi, P. Therond, S. Chantepie, M. Couturier, K.A. Rye, M.J. Chapman, and et al. HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis Arterioscler Thromb Vasc Biol 29 2009 2169 2175
218. B. Zhang, H. Tomura, A. Kuwabara, T. Kimura, S. Miura, K. Noda, and et al. Correlation of high density lipoprotein (HDL)-associated sphingosine 1-phosphate with serum levels of HDL-cholesterol and apolipoproteins Atherosclerosis 178 2005 199 205
219. Y. Zhang, I. Zanotti, M.P. Reilly, J.M. Glick, G.H. Rothblat, and D.J. Rader Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo Circulation 108 2003 661 663
220. Y. Zhao, D.L. Sparks, and Y.L. Marcel Specific phospholipid association with apolipoprotein A-I stimulates cholesterol efflux from human fibroblasts. Studies with reconstituted sonicated lipoproteins J Biol Chem 271 1996 25145 25151